Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-14 Purchase | 2021-09-14 09:59 am | Translate Bio Inc. | TBIO | Sanofi 10% Owner | 71,983,597 | $38 | $2,735,376,686 | 75,668,031 (Direct) | View |
| 2021-08-02 Purchase | 2021-08-02 8:34 pm | Icosavax Inc. | ICVX | Sanofi 10% Owner | 66,667 | $15 | $1,000,005 | 3,155,169 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-29 06:06 am | Inozyme Pharma Inc. | INZY | Sanofi 10% Owner | 81,250 | $16 | $1,300,000 | 520,125 (Indirect) | View |
| 2020-06-09 Sale | 2020-06-11 6:45 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 120,234 | $597.48 | $71,837,410 | 279,766 (Indirect) | View |
| 2020-05-29 Sale | 2020-05-29 4:16 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 22,821,451 | $509.85 | $11,635,516,792 | 400,000 (Indirect Direct) | View |
| 2020-03-09 Sale | 2020-03-11 5:00 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 128,914 | $489.65 | $63,123,153 | 23,221,451 (Indirect Direct) | View |
| 2019-09-10 Sale | 2019-09-12 5:00 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 172,904 | $281.15 | $48,611,804 | 23,350,365 (Indirect Direct) | View |
| 2019-07-22 Purchase | 2019-07-23 11:39 am | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 93,750 | $16 | $1,500,000 | 558,035 (Indirect) | View |
| 2019-03-08 Sale | 2019-03-12 8:19 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 131,115 | $412.17 | $54,041,316 | 23,523,269 (Indirect Direct) | View |
| 2019-02-13 Sale | 2019-02-15 06:05 am | MyoKardia Inc | MYOK | Sanofi 10% Owner | 4,168,899 | $37.66 | $157,000,736 | 0 (Indirect) | View |
| 2018-09-06 Sale | 2018-09-10 5:01 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 104,552 | $406.68 | $42,519,249 | 23,654,384 (Indirect) | View |
| 2018-06-08 Sale | 2018-06-11 4:30 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 121,601 | $309.31 | $37,611,882 | 23,758,936 (Indirect) | View |
| 2018-05-25 Purchase | 2018-05-29 4:34 pm | MyoKardia Inc | MYOK | Sanofi 10% Owner | 150,000 | $49 | $7,350,000 | 4,168,899 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-08-02 Ownership | 2021-08-12 4:00 pm | N/A N/A | Translate Bio Inc. | TBIO | Sanofi See Remarks below | 0 | $0 | 3,684,434 (Direct) | View |
| 2021-08-02 Conversion | 2021-08-02 8:34 pm | N/A N/A | Icosavax Inc. | ICVX | Sanofi 10% Owner | 15,923,393 | $0 | 3,155,169 (Indirect) | View |
| 2021-07-28 Ownership | 2021-07-28 8:32 pm | N/A N/A | Icosavax Inc. | ICVX | Sanofi 10% Owner | 0 | $0 | 3,088,502 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-29 06:06 am | N/A N/A | Inozyme Pharma Inc. | INZY | Sanofi 10% Owner | 3,718,595 | $0 | 520,125 (Indirect) | View |
| 2020-07-23 Ownership | 2020-07-23 9:04 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Sanofi 10% Owner | 0 | $0 | 438,875 (Indirect) | View |
| 2019-07-22 Conversion | 2019-07-23 11:39 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 3,714,285 | $0 | 558,035 (Indirect) | View |
| 2019-07-17 Ownership | 2019-07-17 7:30 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 0 | $0 | 464,285 (Indirect) | View |